Recently, Leadinno Medical Valley (hereinafter referred to as "Leadinno Medical Valley") has completed an A+ round of financing of over 100 million RMB. This round of financing was led by Fortune Venture Capital, with Wuxi Zhaofeng Lifu participating in the investment.
The raised funds will be used for the research, development, production of Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) products, as well as for company operations.
Leadinno Medical Valley was founded in 2016, focusing on the research and development of innovative neuro-modulation technologies and the construction and development of pain management departments in China. The company has appointed Academician Han Jisheng, a pioneer in the field of pain management in China, and Professor Fan Bifa, an academic leader in Chinese pain science, as chief scientists. It provides innovative products and professional solutions for pain management and neuro-modulation treatments, promoting the development of innovative clinical application technologies.
With the rise of brain science, neuromodulation technology has become a research hotspot in the medical field and an important treatment method for various diseases. In the field of brain science research, the main areas are divided into "reading the brain" and "controlling the brain." The most important clinical application of brain control technology at present is neuromodulation technology.
Leadinno Medical Valley, based on years of industry experience and addressing the clinical needs and limitations of IPG-type products, has proposed four key requirements: "simplified surgery, miniaturized implants, sufficient energy, and low cost," establishing an innovative wireless power-carrying neuromodulation technology platform. Wireless power-carrying implant devices reduce patients' payment costs while significantly improving their comfort; the innovative technology lowers the learning curve for doctors, enabling physicians at grassroots hospitals to master the surgical techniques, thereby allowing more patients to benefit from better treatment options.
Starting with SCS, Leadinno Medical Valley has independently developed China's first wireless-powered implantable neurostimulation product. This product can overcome the clinical application limitations of traditional active implantable neurostimulation devices, and is expected to bring more comfortable and effective treatment solutions to hundreds of millions of chronic pain patients worldwide.
In addition, the company is rapidly expanding its product line, and the PNS product has also entered the research and development stage. Similar to the SCS product, the PNS product also uses wireless power transfer technology for electrical stimulation therapy of peripheral nerves.